The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Medical Morphine-Global Market Insights and Sales Trends 2024
Synopsis
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
The global Medical Morphine market size is expected to reach US$ 12900 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Medical Morphine in various end use industries. The expanding demands from the Cancer and Arthritis, are propelling Medical Morphine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectables segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Morphine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Morphine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Morphine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Morphine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Morphine covered in this report include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Pfizer, Sun Pharmaceutical Industries and Taj Pharmaceuticals Limited, etc.
The global Medical Morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Global Medical Morphine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Morphine market, Segment by Type:
Oral
Injectables
Global Medical Morphine market, by Application
Cancer
Arthritis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Medical Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Morphine is a pain medication of the opiate variety which is found naturally in a number of plants and animals. It acts directly on the central nervous system (CNS) to decrease the feeling of pain. It can be taken for both acute pain and chronic pain. It is frequently used for pain from myocardial infarction and during labour. It can be given by mouth, by injection into a muscle, by injecting under the skin, intravenously, into the space around the spinal cord, or rectally. Maximum effect is around 20 minutes when given intravenously and 60 minutes when given by mouth, while duration of effect is 3–7 hours. Long-acting formulations also exist.
The global Medical Morphine market size is expected to reach US$ 12900 million by 2029, growing at a CAGR of 2.3% from 2023 to 2029. The market is mainly driven by the significant applications of Medical Morphine in various end use industries. The expanding demands from the Cancer and Arthritis, are propelling Medical Morphine market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injectables segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Medical Morphine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Medical Morphine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Medical Morphine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Medical Morphine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Medical Morphine covered in this report include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Pfizer, Sun Pharmaceutical Industries and Taj Pharmaceuticals Limited, etc.
The global Medical Morphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Pfizer
Sun Pharmaceutical Industries
Taj Pharmaceuticals Limited
Global Medical Morphine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Morphine market, Segment by Type:
Oral
Injectables
Global Medical Morphine market, by Application
Cancer
Arthritis
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Medical Morphine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Medical Morphine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Medical Morphine Market Overview
1.1 Medical Morphine Product Overview
1.2 Medical Morphine Market Segment by Type
1.2.1 Oral
1.2.2 Injectables
1.3 Global Medical Morphine Market Size by Type
1.3.1 Global Medical Morphine Market Size Overview by Type (2018-2029)
1.3.2 Global Medical Morphine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Medical Morphine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Medical Morphine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Medical Morphine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Medical Morphine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Medical Morphine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Medical Morphine Sales Breakdown by Type (2018-2023)
2 Global Medical Morphine Market Competition by Company
2.1 Global Top Players by Medical Morphine Sales (2018-2023)
2.2 Global Top Players by Medical Morphine Revenue (2018-2023)
2.3 Global Top Players by Medical Morphine Price (2018-2023)
2.4 Global Top Manufacturers Medical Morphine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Medical Morphine Market Competitive Situation and Trends
2.5.1 Medical Morphine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Medical Morphine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Medical Morphine as of 2022)
2.7 Date of Key Manufacturers Enter into Medical Morphine Market
2.8 Key Manufacturers Medical Morphine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Medical Morphine Status and Outlook by Region
3.1 Global Medical Morphine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Medical Morphine Historic Market Size by Region
3.2.1 Global Medical Morphine Sales in Volume by Region (2018-2023)
3.2.2 Global Medical Morphine Sales in Value by Region (2018-2023)
3.2.3 Global Medical Morphine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Medical Morphine Forecasted Market Size by Region
3.3.1 Global Medical Morphine Sales in Volume by Region (2024-2029)
3.3.2 Global Medical Morphine Sales in Value by Region (2024-2029)
3.3.3 Global Medical Morphine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Medical Morphine by Application
4.1 Medical Morphine Market Segment by Application
4.1.1 Cancer
4.1.2 Arthritis
4.2 Global Medical Morphine Market Size by Application
4.2.1 Global Medical Morphine Market Size Overview by Application (2018-2029)
4.2.2 Global Medical Morphine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Medical Morphine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Medical Morphine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Medical Morphine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Medical Morphine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Medical Morphine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Medical Morphine Sales Breakdown by Application (2018-2023)
5 North America Medical Morphine by Country
5.1 North America Medical Morphine Historic Market Size by Country
5.1.1 North America Medical Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Medical Morphine Sales in Volume by Country (2018-2023)
5.1.3 North America Medical Morphine Sales in Value by Country (2018-2023)
5.2 North America Medical Morphine Forecasted Market Size by Country
5.2.1 North America Medical Morphine Sales in Volume by Country (2024-2029)
5.2.2 North America Medical Morphine Sales in Value by Country (2024-2029)
6 Europe Medical Morphine by Country
6.1 Europe Medical Morphine Historic Market Size by Country
6.1.1 Europe Medical Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Medical Morphine Sales in Volume by Country (2018-2023)
6.1.3 Europe Medical Morphine Sales in Value by Country (2018-2023)
6.2 Europe Medical Morphine Forecasted Market Size by Country
6.2.1 Europe Medical Morphine Sales in Volume by Country (2024-2029)
6.2.2 Europe Medical Morphine Sales in Value by Country (2024-2029)
7 Asia-Pacific Medical Morphine by Region
7.1 Asia-Pacific Medical Morphine Historic Market Size by Region
7.1.1 Asia-Pacific Medical Morphine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Medical Morphine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Medical Morphine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Medical Morphine Forecasted Market Size by Region
7.2.1 Asia-Pacific Medical Morphine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Medical Morphine Sales in Value by Region (2024-2029)
8 Latin America Medical Morphine by Country
8.1 Latin America Medical Morphine Historic Market Size by Country
8.1.1 Latin America Medical Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Medical Morphine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Medical Morphine Sales in Value by Country (2018-2023)
8.2 Latin America Medical Morphine Forecasted Market Size by Country
8.2.1 Latin America Medical Morphine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Medical Morphine Sales in Value by Country (2024-2029)
9 Middle East and Africa Medical Morphine by Country
9.1 Middle East and Africa Medical Morphine Historic Market Size by Country
9.1.1 Middle East and Africa Medical Morphine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Medical Morphine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Medical Morphine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Medical Morphine Forecasted Market Size by Country
9.2.1 Middle East and Africa Medical Morphine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Medical Morphine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Mallinckrodt Pharmaceuticals
10.1.1 Mallinckrodt Pharmaceuticals Company Information
10.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
10.1.3 Mallinckrodt Pharmaceuticals Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mallinckrodt Pharmaceuticals Medical Morphine Products Offered
10.1.5 Mallinckrodt Pharmaceuticals Recent Development
10.2 Alcaliber
10.2.1 Alcaliber Company Information
10.2.2 Alcaliber Introduction and Business Overview
10.2.3 Alcaliber Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Alcaliber Medical Morphine Products Offered
10.2.5 Alcaliber Recent Development
10.3 Purdue Pharma
10.3.1 Purdue Pharma Company Information
10.3.2 Purdue Pharma Introduction and Business Overview
10.3.3 Purdue Pharma Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Purdue Pharma Medical Morphine Products Offered
10.3.5 Purdue Pharma Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Medical Morphine Products Offered
10.4.5 Pfizer Recent Development
10.5 Sun Pharmaceutical Industries
10.5.1 Sun Pharmaceutical Industries Company Information
10.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.5.3 Sun Pharmaceutical Industries Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Sun Pharmaceutical Industries Medical Morphine Products Offered
10.5.5 Sun Pharmaceutical Industries Recent Development
10.6 Taj Pharmaceuticals Limited
10.6.1 Taj Pharmaceuticals Limited Company Information
10.6.2 Taj Pharmaceuticals Limited Introduction and Business Overview
10.6.3 Taj Pharmaceuticals Limited Medical Morphine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Taj Pharmaceuticals Limited Medical Morphine Products Offered
10.6.5 Taj Pharmaceuticals Limited Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Medical Morphine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Medical Morphine Industrial Chain Analysis
11.4 Medical Morphine Market Dynamics
11.4.1 Medical Morphine Industry Trends
11.4.2 Medical Morphine Market Drivers
11.4.3 Medical Morphine Market Challenges
11.4.4 Medical Morphine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Medical Morphine Distributors
12.3 Medical Morphine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
